The Bone Density Stack: Calcium, Vitamin D, K2, and Magnesium

Bone density supplementation is poorly understood by most people who take it. The biggest gains come from resistance training and adequate protein, not from calcium pills. But four nutrients have RCT-level evidence for measurable DXA outcomes when supplied in the right amounts: calcium to the RDA (not above), vitamin D to a serum 25-OH-D in the 30–50 ng/mL range, vitamin K2 to support matrix carboxylation, and magnesium because it is a cofactor for the entire calcium-handling system. None of these are useful in isolation; they are mutually dependent.

Layer 1: Calcium — To Meet, Not Exceed, the RDA

The most important calcium fact is that more is not better. The RDA is 1,000 mg daily for adults under 50, 1,200 mg for women over 50 and men over 70. If you reach that from diet, supplement zero. The Women's Health Initiative and several meta-analyses found that calcium supplementation above 1,000 mg daily was associated with a small increased risk of cardiovascular events and kidney stones with limited bone fracture benefit. The Cochrane 2024 update reaffirmed that calcium alone produces only a modest increase in BMD and a small reduction in vertebral fracture risk in postmenopausal women, principally in those with intakes below the RDA. Use calcium citrate (better absorption fasted or in adults on PPIs) at 500 mg per dose; never take more than 600 mg of supplemental calcium at once. See our calcium harm/benefit analysis.

Layer 2: Vitamin D3 — Dose to a Serum Level, Not a Daily IU Target

Vitamin D3 is essential for active calcium absorption from the gut and for muscle function in fall prevention. Supplement to a serum 25-OH-D of 30–50 ng/mL (75–125 nmol/L); fixed-dose protocols (e.g. 2,000 IU daily) get most adults into that range but the right answer is to measure and adjust. The VITAL trial of 25,871 adults supplementing 2,000 IU vitamin D3 plus 1 g omega-3 daily found no reduction in fracture incidence over 5 years versus placebo in healthy adults already mostly D-replete — supporting the view that vitamin D's bone benefit is specifically deficiency-correction, not universal supplementation. In adults with serum below 20 ng/mL, repletion improves intestinal calcium absorption and meaningfully reduces fall risk. See our vitamin D dose guide.

Layer 3: Vitamin K2 (MK-7), 100–180 mcg Daily

Vitamin K2 activates osteocalcin, the protein that binds calcium to bone matrix. Without sufficient K2, osteocalcin remains undercarboxylated and calcium goes preferentially to soft tissues (arteries) instead of bone. The strongest RCT evidence is Knapen 2013, a three-year trial in postmenopausal women showing that MK-7 180 mcg daily improved both lumbar spine and femoral neck BMD versus placebo. The Japanese pharmaceutical dose for osteoporosis (MK-4 at 45 mg daily) has stronger fracture-prevention data but at a far higher dose than typical supplements provide. MK-7 at 100–180 mcg daily is the practical compromise. Avoid in adults on warfarin without anticoagulation input. See the K2 evidence overview.

Layer 4: Magnesium, 250–350 mg Elemental Daily

Magnesium is involved in roughly 60% of total body magnesium being stored in bone, and serum magnesium correlates positively with BMD in observational cohorts. RCT evidence is thinner than for the first three layers but a 2014 trial in postmenopausal women showed that magnesium oxide 1,830 mg daily for 30 days improved BMD modestly versus placebo. The mechanism includes activation of vitamin D's 1-alpha-hydroxylase, regulation of PTH, and direct effects on osteoblast function. Magnesium glycinate or citrate at 250–350 mg elemental daily is reasonable; do not exceed 350 mg without a check on renal function. See our magnesium form comparison.

What NOT to Add

Strontium ranelate had positive BMD trial data but was withdrawn in most jurisdictions due to cardiovascular and skin-toxicity signals; the supplement form (strontium citrate) has no equivalent fracture evidence and inflates DXA artifactually because strontium has higher atomic number than calcium. Skip "bone broth collagen" as a bone density intervention — see our collagen review for what it actually does. Boron has weak BMD signals. For pharmacological bone density gain in established osteoporosis, denosumab, bisphosphonates, or anabolic agents like teriparatide vastly outperform any supplement combination — see the osteoporosis condition page.

How to Run the Stack and Bottom Line

Start with diet — calculate dietary calcium intake from dairy and leafy greens, supplement only the gap to the RDA. Test serum 25-OH-D and dose D3 to 30–50 ng/mL. Add K2 (MK-7) and magnesium routinely. Re-evaluate with a DXA scan every 2 years if at risk. This stack is a foundation, not a treatment. In established osteoporosis (T-score ≤ –2.5), supplements alone will not prevent fractures; pharmacotherapy plus resistance training is the standard.